Hey Crew!

When Carli's cancer came back in October 2024, we made a different choice the second time around. We stopped trusting the system blindly and started reading the research ourselves.

What we found on PubMed, the government's own medical database, changed everything.

185 peer-reviewed studies. Off-patent compounds. Real anti-cancer effects.

I recorded a short walkthrough so you know exactly what's inside the PDF and how to use it. Watch it below 👇

We're not telling you to abandon all conventional treatment. We're saying that sometimes the bravest thing you can do is trust your intuition when the entire medical establishment offers solutions that don't fit your specific situation.

The compounds showing the most promise across the studies:

  • Ivermectin: Nobel Prize-winning antiparasitic

  • Mebendazole: over a dozen oncology studies

  • Methylene Blue: therapeutic dye with real research behind it

  • Hydroxychloroquine: antimalarial with promising data

Remember: this isn't medical advice. It's information. What you do with it is between you and whatever medical team you trust.

Every time we try to share this research on social media, it gets banned. We're not sure why peer-reviewed government data violates "community standards," but here we are.

Your oncologist probably hasn't mentioned any of this. Not out of malice, but because recommending a $9 compound for cancer is career suicide inside their system, even when the research supports it. That's not a conspiracy. That's liability.

If this resonates, come join us inside Cancer Crew Plus. It's where we share what's actually working, without the censorship.

With heart,
Carli
Founder of The Cancer Crew

Interested in reaching our audience? You can sponsor our newsletter here.

Help us make the next issue even better by picking the option that fits you best.

Must-Reads You Might’ve Missed

185 PubMed Studies Your Doctor Doesn't Want You to Know

Anti-Parasitic Protocols For Cancer Patients

Will Anti-Parasitic Drugs Work For MY Cancer?

Reply

Avatar

or to participate

Keep Reading